Taiwan FDA registration a5ee650910849d14e5c464162e529a12
Demarf hyaluronic acid "Roufu" (with lidocaine)
TW: 德瑪芙玻尿酸“柔芙”(含利多卡因)
Taiwan·Risk Class 3·COLLAMATRIX CO., LTD.·Registered Jul 10, 2024 – Jul 10, 2029ActiveRegistration details
- Analysis ID
- a5ee650910849d14e5c464162e529a12
Company information
- Manufacturer
- COLLAMATRIX CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- COLLAMATRIX CO., LTD.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.0007 Hyaluronic acid implants
- Import Information
- Domestic;; Security surveillance
Dates and status
- Registration Date
- Jul 10, 2024
- Expiry Date
- Jul 10, 2029
About this record
Access comprehensive regulatory information for Demarf hyaluronic acid "Roufu" (with lidocaine) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a5ee650910849d14e5c464162e529a12 and manufactured by COLLAMATRIX CO., LTD.. The authorized representative in Taiwan is COLLAMATRIX CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices